论文部分内容阅读
环丙沙星是合成抗菌药喹诺酮类新产品,是已上市的同类产品中抗菌作用最强、抗菌谱最广的一个。本临床试验旨在观察国产环丙沙星治疗细菌性感染的临床疗效及不良反应,选用已知有效药物为对照药进行随机对照试验,泌尿道与肠道感染选用环丙沙星的同类品种诺氟沙星为对照药各观察22例;呼吸道感染与其他全身感染11例与对照药头孢氨苄12例进行对照。剂量为环丙沙星口服200 mg,3次/d,或400
Ciprofloxacin is a synthetic antibacterial quinolone new products, is already listed in similar products in the strongest antibacterial, antibacterial spectrum of the most extensive one. The purpose of this clinical trial is to observe the clinical efficacy and adverse reactions of domestic ciprofloxacin in the treatment of bacterial infections. Randomly controlled trials were conducted using known effective drugs as control drugs. Urinary tract and intestinal infections selected the same type of ciprofloxacin Ofloxacin for the control drug were observed in 22 cases; respiratory tract infection and other systemic infections in 11 cases and control drug cephalexin in 12 cases. The dose of ciprofloxacin 200 mg orally, 3 times / d, or 400